Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating bevacizumab in combination with docetaxel and cisplatin for metastatic or locally advanced non-small cell lung cancer; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab) (bevacizumab)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-07-10